Follow-Up Colonoscopy Rate Low Within Six Months of Abnormal Stool Test
By Elana Gotkine HealthDay Reporter
WEDNESDAY, March 27, 2024 -- Fewer than half of adults have a follow-up colonoscopy within six months following an abnormal stool-based screening test (SBT) for colorectal cancer (CRC), according to a study published online March 25 in JAMA Network Open.
Elizabeth L. Ciemins, Ph.D., M.P.H., from the American Medical Group Association in Alexandria, Virginia, and colleagues conducted a retrospective quality improvement study to develop and test a quality performance measure for follow-up colonoscopy within six months of an abnormal result of an SBT for CRC. To determine follow-up colonoscopy rates within six months in a database study, adults from 38 health care organizations (HCOs) aged 50 to 75 years who completed an initial CRC SBT with an abnormal result were observed.
The researchers found that 47.9 percent of the 20,581 adults in 38 health systems had a follow-up colonoscopy following an abnormal SBT result for CRC within six months. Significant variation was seen between HCOs. Follow-up colonoscopy was received by significantly fewer Black patients (37.1 percent) and patients with Medicare or Medicaid insurance (49.2 and 39.2 percent, respectively). A quality performance measure that tracks rates of follow-up within six months of an abnormal SBT result was feasible, valid, and reliable; the median reliability statistic was 94.5 percent between HCOs.
"Use of SBTs may increase overall screening rates, but abnormal results must be followed up with a colonoscopy to diagnose CRC -- ideally as soon as possible, but definitely within the six months after an abnormal test result," the authors write.
One author disclosed ties to Exact Sciences.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
Mortality in Rheumatic Heart Disease Is High
FRIDAY, June 7, 2024 -- Mortality related to rheumatic heart disease (RHD) is high and is correlated with the severity of valve disease, according to a study published online June...
Higher County-Level Prostate Cancer Screening Tied to Better Outcomes
FRIDAY, June 7, 2024 -- Higher county-level prevalence of prostate-specific antigen (PSA) screening is associated with lower odds of advanced disease, all-cause mortality, and...
Metabolic Impact on Offspring Similar for Frozen, Fresh Embryo Transfer
FRIDAY, June 7, 2024 -- For glucose and lipid profiles during early childhood, the impact of frozen embryo transfer (FET) is comparable to that of fresh embryo transfer, according...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.